Hologic (NASDAQ: HOLX), a medical imaging company, is recently trading down 71 cents to $20.22 in pre-open trading.
Soleil says: "downgrading HOLX from Buy to Hold following our confirmation from the FDA that the tentative date for Radiological Devices Panel (8.12.08) has been canceled-an action which reads negative for HOLX."
HOLX over all option implied volatility of 46 is above its 26-week average of 43 according to Track Data, suggesting larger price uncertainty.
Option Update is provided by Stock Specialist Paul Foster of theflyonthewall.com
Stock picks and pans for troubled times: RIMM, ED, ISRG, GLW, LEA, SLB, GOOG ...
Is Berkshire Hathaway better than S&P Index?
Closing Bell: Torch Passing on a Friday Rally
